Characterization of epidermal growth factor-related proteins from human urinary chorionic gonadotrophin
- 1 November 1989
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 123 (2) , 333-340
- https://doi.org/10.1677/joe.0.1230333
Abstract
A urinary chorionic gonadotrophin (hCG) preparation, mitogenic for ovarian carcinoma cells, was analysed by gel filtration through Sephadex G-100 Superfine. The resulting fractions were tested for hCG and for properties of the epidermal growth factor (EGF) by radioimmunoassays (RIA) in comparison with their ability to stimulate the growth of EFO27nu ovarian carcinoma cells. The elution profile of the RIA activities for hCG corresponded to molecular weights of 12 and 71 kDa, whereas the mitogenic activity was found in peak fractions eluting at 7, 11 and 52 kDa, indicating the presence of mitogenic substances distinct from hCG or its β-subunit. In comparison experiments, radiolabelled recombinant human EGF eluted at 7 kDa from the column. The profile of EGF immunoreactivity determined in the eluant fractions of hCG preparation A correlated with the mitogenic potential. Eluant fractions with growth-promoting activity competed with 125I-labelled EGF in binding to EFO-27nu cells; the inhibition of EGF binding was correlated with the mitogenic potential and the EGF immunoreactivity. We assume that the 7 kDa component of the gel filtration eluate corresponds to monomeric EGF; the high molecular weight mitogens may represent EGF precursor protein fragments of various molecular size classes. Journal of Endocrinology (1989) 123, 333–340This publication has 26 references indexed in Scilit:
- In Vitro Growth Promotion of Human Mammary Carcinoma Cells by Steroid Hormones, Tamoxifen, and Prolactin23JNCI Journal of the National Cancer Institute, 1984
- Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis2JNCI Journal of the National Cancer Institute, 1983
- Cell Lines Derived from Human Ovarian Carcinomas: Growth Stimulation by Gonadotropic and Steroid Hormones23JNCI Journal of the National Cancer Institute, 1983
- Transforming Growth Factors in the Urine of Normal, Pregnant, and Tumor-Bearing Humans2JNCI Journal of the National Cancer Institute, 1982
- Biological and Immunological Characterization of Crude Commercial Human Choriogonadotropin*Journal of Clinical Endocrinology & Metabolism, 1982
- Characterization of a Discrete Degradation Product of the Human Chorionic Gonadotropin β-Subunit in HumansJournal of Clinical Endocrinology & Metabolism, 1980
- Hormonal profile of the cycle in 68 normally menstruating womenActa Endocrinologica, 1980
- Plasma Concentrations of Immunoreactive Human Epidermal Growth Factor (Urogastrone) in Man*Journal of Clinical Endocrinology & Metabolism, 1980
- Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations.Journal of Clinical Investigation, 1978
- OVARIAN TUMORS1977